Open Beta
TREN
MetriLume
TREN

US marketsBDSX

SEC-sourced researchBeta

BDSX

BIODESIX INC

Company comparison ↗

Data passport

CIK
0001439725
Exchange
Nasdaq
Business activity
Services-Medical Laboratories · SIC 8071
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 71,323,000.0000 USD; December 2025: 88,499,000.0000 USD88.5M USD0 USD0December 2024December 2025
BDSX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202471,323,000.0000Feb 26, 2026
December 202588,499,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202588,499,000.0000-35,265,000.0000-23,271,000.000087,476,000.000089,941,000.0000Feb 26, 2026
December 202471,323,000.0000-42,931,000.0000-48,649,000.000097,244,000.000076,368,000.0000Feb 26, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

35/100
Profitability0
Growth74
Balance sheet0
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$88.5MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Previous period revenueRevenues$71.32MJan 1, 2024 – Dec 31, 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$35.27MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$23.27MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Total assetsAssets$87.48MDec 31, 2025Feb 26, 202610-K
Total liabilitiesLiabilities$89.94MDec 31, 2025Feb 26, 202610-K

New filings

Explore methodology ↗